New drug approvals: July 2018
July has seen a plethora of new drug approvals, including the US FDA's approval of iobenguane I 131, the first and only treatment for a rare adrenal cancer. Find out more in this round-up of the new therapies on the market.
Please sign in or register for FREE
Sign in to RxNet
Register to RxNet
RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.